ASCO GI 2022 Conference Coverage
Playback speed
10 seconds
ASCO GI 2022 Updates on IMbrave150 Trial: Exploratory Efficacy & Safety in Unresectable HCC Treated With Atezo Beyond Radiological Progression Until the Loss of Clinical Benefit
By
ASCO GI 2022 Conference Coverage
FEATURING
Han Chong Toh
By
ASCO GI 2022 Conference Coverage
FEATURING
Han Chong Toh
93 views
January 26, 2022
Login to view comments.
Click here to Login
Videos